Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Switching of BJT

Switching of BJT

Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...

Biodiversity and Human Values

Biodiversity and Human Values

Human civilization relies on biodiversity in many ways. Sudden changes in species biodiversity result in environmental changes that can modify weather patterns and therefore human civilizations.

Molecular Models

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

The Bohr Model

The Bohr Model

Following the work of Ernest Rutherford and his colleagues in the early twentieth century, the picture of atoms consisting of tiny dense nuclei surrounded by lighter and even tinier electrons continually moving about the nucleus was well established. This picture was called the planetary model since it pictured the atom as a miniature “solar system” with the electrons orbiting the nucleus like planets orbiting the sun. The simplest atom is hydrogen, consisting of a single proton as the...

Requirements for Human Life

Requirements for Human Life

The Earth and its atmosphere have provided humans with air, water, and food, but these are not the only requirements for survival. Humans also require a specific range of temperature and pressure that the Earth and its atmosphere provides.
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MNT: a new target for AML.

Blood neoplasia·2025

Same author

Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.

Nature communications·2025

Same author

Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.

Nature communications·2025

Same author

Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy.

Developmental cell·2024

Same author

Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers.

Cancer cell·2024

Same author

Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses.

Cell death and differentiation·2023

Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026

Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026

Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026

Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026

Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026

Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 31, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Modelling human haemoglobin switching.

Sarah T Diepstraten¹, Adam H Hart¹

¹Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia.

|January 9, 2019

Summary

This summary is machine-generated.

Researchers are evaluating cell and animal models to develop new medicines for beta-haemoglobinopathies like sickle cell disease and beta-thalassemia. These models help test novel gene therapies and precision medicines.

Keywords:

Beta-thalassemia Erythropoiesis Haemoglobin switching Model systems Sickle cell disease

More Related Videos

Measuring the Switch Cost of Smartphone Use While Walking

Measuring the Switch Cost of Smartphone Use While Walking

Published on: April 30, 2020

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

Related Experiment Videos

Last Updated: Jan 31, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Measuring the Switch Cost of Smartphone Use While Walking

Measuring the Switch Cost of Smartphone Use While Walking

Published on: April 30, 2020

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

Area of Science:

Genetics and Molecular Medicine
Hematology
Drug Discovery

Background:

Genetic mutations in the beta-globin gene cause serious blood disorders, including beta-thalassemia and sickle cell disease.
Developing effective molecular therapies requires understanding the complex human globin gene locus and species-specific differences in blood development.
Epigenetic factors also play a crucial role in the regulation of globin gene expression.

Purpose of the Study:

To compare and contrast current cell-based and animal models used for studying beta-haemoglobinopathies.
To highlight the complementary strengths of various in vitro and in vivo models.
To review the progress and future directions of molecular and precision medicines for these genetic blood disorders.

Main Methods:

Comparative analysis of existing cell-based (in vitro) and animal (in vivo) models.
Review of scientific literature on model systems for beta-haemoglobinopathies.
Examination of advances in genome sequencing, gene editing, and precision medicine relevant to therapy development.

Main Results:

Various models possess unique strengths and limitations for studying beta-haemoglobinopathies.
Models have guided the development of therapies targeting globin gene reactivation, repair, or replacement.
A new generation of molecular and precision medicines is emerging, with some already in clinical trials.

Conclusions:

Cell-based and animal models are indispensable tools for advancing the treatment of beta-haemoglobinopathies.
The insights gained from these models are crucial for the successful development of novel gene therapies.
Ongoing research and clinical trials show promise for effective molecular and precision medicines to combat these debilitating genetic blood disorders.